Adoptive immunotherapy of ovarian carcinoma

ARCAD-Asia initiative: leveraging yesterday's data for tomorrow.

ESMO gastrointestinal oncology·2026

Single-cell mRNA-regulation analysis reveals cell type-specific mechanisms of type 2 diabetes.

Nature communications·2025

Promoting large multinational academic clinical trials for gastrointestinal cancers in Europe: the ENGIC (European Network for GI Cancers) initiative.

ESMO open·2025

Impact of tumor and node stages on the efficacy of adjuvant oxaliplatin-based chemotherapy in stage III colon cancer patients: an ACCENT pooled analysis.

ESMO open·2025

Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database.

British journal of cancer·2024

High rates of venous thromboembolism in endometrial cancer patients requiring systemic therapy: an opportunity for risk assessment and intervention.

Gynecologic oncology·2026

Leveraging artificial intelligence in the early detection of ovarian cancer: Development and validation of a risk prediction model.

Gynecologic oncology·2026

The science and conduct of surgical trials in gynecologic oncology: A practical framework.

Gynecologic oncology·2026

Early-phase vs. late-phase clinical trials in gynecologic oncology: Trends in trial completion, reporting, and enrollment of racial and ethnic minority groups.

Gynecologic oncology·2026

Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination-deficient stage III/IV ovarian cancer: Findings from cohort C of the OPAL phase 2 trial.

Gynecologic oncology·2026

Evaluating a patient ambassador program to improve clinical trial knowledge and intent to discuss gynecologic oncology trials.

Gynecologic oncology·2026

[Prophylactic use of tyrosine kinase inhibitors after allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Prolonged engraftment syndrome following autologous stem cell transplantation in Hodgkin lymphoma with prior immune checkpoint inhibitor therapy].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

Type 2 Diabetes Reshapes the B-Cell Compartment in Tuberculosis, with Reduction of Transitional B Cells and Expansion of Plasmablasts.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026

Bacillus Calmette-Guerin in controlling type 1 diabetes: A quasi-experimental randomized clinical trial.

Caspian journal of internal medicine·2026

Single-cell transcriptomic signatures of T cells associated with rituximab responsiveness in idiopathic nephrotic syndrome.

iScience·2026

Telemedicine-guided management of iodinated contrast media-associated anaphylaxis: A case report.

Radiology case reports·2026

Related Experiment Videos

Adoptive immunotherapy of ovarian carcinoma

Related Concept Videos

ARCAD-Asia initiative: leveraging yesterday's data for tomorrow.

Single-cell mRNA-regulation analysis reveals cell type-specific mechanisms of type 2 diabetes.

Promoting large multinational academic clinical trials for gastrointestinal cancers in Europe: the ENGIC (European Network for GI Cancers) initiative.

Impact of tumor and node stages on the efficacy of adjuvant oxaliplatin-based chemotherapy in stage III colon cancer patients: an ACCENT pooled analysis.

Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial.

Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database.

High rates of venous thromboembolism in endometrial cancer patients requiring systemic therapy: an opportunity for risk assessment and intervention.

Leveraging artificial intelligence in the early detection of ovarian cancer: Development and validation of a risk prediction model.

The science and conduct of surgical trials in gynecologic oncology: A practical framework.

Early-phase vs. late-phase clinical trials in gynecologic oncology: Trends in trial completion, reporting, and enrollment of racial and ethnic minority groups.

Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination-deficient stage III/IV ovarian cancer: Findings from cohort C of the OPAL phase 2 trial.

Evaluating a patient ambassador program to improve clinical trial knowledge and intent to discuss gynecologic oncology trials.

[Prophylactic use of tyrosine kinase inhibitors after allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia].

[Prolonged engraftment syndrome following autologous stem cell transplantation in Hodgkin lymphoma with prior immune checkpoint inhibitor therapy].

Type 2 Diabetes Reshapes the B-Cell Compartment in Tuberculosis, with Reduction of Transitional B Cells and Expansion of Plasmablasts.

Bacillus Calmette-Guerin in controlling type 1 diabetes: A quasi-experimental randomized clinical trial.

Single-cell transcriptomic signatures of T cells associated with rituximab responsiveness in idiopathic nephrotic syndrome.

Telemedicine-guided management of iodinated contrast media-associated anaphylaxis: A case report.

Related Experiment Videos

Adoptive immunotherapy of ovarian carcinoma

Related Concept Videos

Related Articles